ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 705323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 705323; 2) Community: the network communities that were significantly associated with the response to NSC 705323; 3) Molecule: the relationships between components within communities and NSC 705323; 4) MDR: the compounds that were significantly associated with the NSC 705323.

NSC Compound Enrichment Correlation
NSC 746351 Null 0.0126882509540132 0.33145102
NSC 748643 Mitaplatin 0.0126882509540132 0.26214539
NSC 753189 3,5-dichloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide 0.0126882509540132 0.2934509
NSC 758671 ANCITABINE HYDROCHLORIDE 0.0126882509540132 0.21993855
NSC 79037 Lomustine 0.0126882509540132 0.39601684
NSC 100880 Camptothecin 0.0126882509540134 0.14883841
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0126882509540134 0.29987956
NSC 269760 B8 0.0126882509540134 0.36794563
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0126882509540134 0.39544923
NSC 42972 Null 0.0126882509540134 0.31611931
Total:62  Current:17    [First] [Prev] [Next] [Last]